Author:
Berrington A.W.,Perry J.D.,Gould F.K.
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference11 articles.
1. In vitro activity of BAY 12–8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis;Brueggemann;Antimicrob Agents Chemother,1997
2. Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible
Staphylococcus aureus
Strains
3. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone administered to healthy subjects;Stass;Antimicrob Agents Chemother,1998
4. In vitro activity of BAY 12–8039, a new fluoroquinolone;Woodcock;Antimicrob Agents Chemother,1997
5. Comparative in vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfbpristin and linezolid against staphylococci;von Eiff;J Antimicrob Chemother,1999
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献